85524-2602-6 : NDC 2026 Code

85524-2602-6 : Glycerin 6%,lidocaine 4%,ectoin 0.12% ( Hemorrhoid And Fissure )

Additionally :

You can get information about “85524-2602-6” NDC code in 85524-2602-6 in HTML format

HTML | 85524-2602-6 in TXT (Plain Text) format

TXT | 85524-2602-6 in PDF (Portable Document Format)

PDF | 85524-2602-6 in XML format

XML formats.

NDC Code : 85524-2602-6 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "85524-2602-6",
    "PackageDescription": "1 BOTTLE in 1 BOX (85524-2602-6)  / 42.5 g in 1 BOTTLE (85524-2602-5) ",
    "NDC11Code": "85524-2602-06",
    "ProductNDC": "85524-2602",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Hemorrhoid And Fissure",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Glycerin 6%,lidocaine 4%,ectoin 0.12%",
    "DosageFormName": "OINTMENT",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20260119",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M015",
    "LabelerName": "FlexiGo Inc",
    "SubstanceName": "ECTOIN; GLYCERIN; LIDOCAINE",
    "StrengthNumber": ".0012; .06; .04",
    "StrengthUnit": "g/g; g/g; g/g",
    "Pharm_Classes": "Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260119",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}